A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells
Authors:
- Mordechai LiscovitchMLMordechai Liscovitch
- Dana RavidDRDana Ravid
- 1 January 2007
- journal article
- editorial
- Published by Elsevier in Cancer Letters
- Vol. 245 (1-2) , 350-352
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Proteomic phenotyping: metastatic and invasive breast cancerCancer Letters, 2004
- Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarraysProceedings of the National Academy of Sciences, 2003
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cellsOncogene, 1997
- An Information-Intensive Approach to the Molecular Pharmacology of CancerScience, 1997
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI: Journal of the National Cancer Institute, 1991
- Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleateCancer Chemotherapy and Pharmacology, 1988
- Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.Proceedings of the National Academy of Sciences, 1986